Activation of latent transforming growth factor-β1 is induced by mannose 6-phosphate/insulin-like growth factor-II receptor

Wound Repair and Regeneration

Volumn 8, Issue 6, 2000, Pages 538-546

  Yang, L ^a   Tredget, E E ^a   Ghahary, A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CALCIUM PHOSPHATE; CYSTAMINE; FRUCTOSE 6 PHOSPHATE; MANNOSE 6 PHOSPHATE; MANNOSE PHOSPHATE; NEUTRALIZING ANTIBODY; PLASMIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SOMATOMEDIN B RECEPTOR; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAT; LUNG; LUNG ALVEOLUS EPITHELIUM; MINK; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

ANIMALS; CELL DIVISION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; MANNOSE-6-PHOSPHATE ISOMERASE; MICE; MICE, KNOCKOUT; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034477043     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.2000.00538.x     Document Type: Article

References (37)

1. The transforming growth factor-βs
2. The transforming growth factor-β family
3. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
4. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death
5. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes
6. Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction
7. Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-β1 precursor
8. Latent transforming growth factor-β: Structural features and mechanisms of activation
9. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium
10. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin
11. Cell-associated activation of latent transforming growth factor-β by calpain
12. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism
13. Thrombospondin binds and activates the small and large forms of transforming growth factor-β in a chemically defined system
14. Thrombospondin-1 is a major activator of TGF-β1 in vivo
15. The integrin αvβ6 binds and activates latent TGF-β1: A mechanism for regulating pulmonary inflammation and fibrosis
16. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: Regulation of plasminogen activator activity
17. Activation of transforming growth factor-β is inhibited in transgenic apolipo-protein (a) mice
18. Insulin-like growth factor II receptor as a multi-functional binding protein
19. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor
20. Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid
21. Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells
22. Activation of the bone-derived latent TGF beta complex by isolated osteoclasts
23. Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis
24. Mechanism of retinoid-induced activation of latent transforming growth factor-β in bovine endothelial cells
25. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-β1
26. Structure and function of the mannose 6-phosphate/insulin like growth factor II receptor
27. Cellular response to latent TGF-β1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptor on MS-9 cells
28. Genetically modified dermal keratinocytes express high levels of transforming growth factor-β1
29. The overexpressed human 46-kDa mannose 6-phosphate receptor mediates endocytosis and sorting of β-glucuronidase
30. Insulin-like growth factor-II/mannose-6-phosphate receptors facilitate the matrix effects of latent transforming growth factor-β1 released from genetically modified keratinocytes in a fibroblast/keratinocyte coculture system
31. Uterine insulin-like growth factor-1 receptors: Regulation of estrogen and variation through the estrogen cycle
32. Characterization of the activation of latent TGF-β by cocultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system
33. Characterization of latent TGF-β activation by murine peritoneal macrophages
34. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β
35. Transglutaminases catalyze cross-linking of plasminogen to fibronectin and human endothelial cells
36. Regulation of tissue transglutaminase gene expression as a molecular model for retinoid effects on proliferation and differentiation
37. Retinol-induced morphological changes of cultured bovine endothelial cells are accompanied by a marked increase in transglutaminase